COMMITMENTS AND CONTINGENCIES (Details Narrative) - USD ($)  | 
Feb. 25, 2025  | 
Nov. 15, 2024  | 
Dec. 17, 2024  | 
Nov. 13, 2024  | 
|---|---|---|---|---|
| Loss Contingencies [Line Items] | ||||
| Allegation description | the Company received a Civil Investigation Demand regarding an investigation to determine whether there is or has been a violation of 31 U.S.C. 372 the False Claims Act concerning allegations of false claims submitted to federal programs for approval, payment, and subsequent forgiveness of a Kim International LLC (a subsidiary of Kushco which the Company acquired in 2021) 2020 Federal Payment Protection Program (“PPP) loan of approximately $1.9 million dollars. | |||
| Pryor Cashman [Member] | ||||
| Loss Contingencies [Line Items] | ||||
| Unpaid legal proceedings | $ 320,511.48 | |||
| Crossmark Inc [Member] | ||||
| Loss Contingencies [Line Items] | ||||
| Breach of contract | $ 297,181.90 | |||
| Vaporous Technologies Inc [Member] | ||||
| Loss Contingencies [Line Items] | ||||
| Damages sought value | $ 664,289.43 | 
| X | ||||||||||
- References No definition available. 
  | 
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef 
  | 
| X | ||||||||||
- Definition Amount of loss contingency liability. Reference 1: http://www.xbrl.org/2003/role/disclosureRef 
  | 
| X | ||||||||||
- Definition Presents an assertion of a fact by a plaintiff in a pleading or complaint, which the plaintiff claims it will prove upon presentation of evidence at the proceeding. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef 
  | 
| X | ||||||||||
- Definition The value (monetary amount) of the award the plaintiff seeks in the legal matter. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef 
  | 
| X | ||||||||||
- Details 
  | 
| X | ||||||||||
- Details 
  | 
| X | ||||||||||
- Details 
  |